|
Mr. Katzer is responsible for the leadership and management of all manufacturing and global distribution of the Company's Surfactant Replacement Therapy products. Mr. Katzer has extensive expertise in the sterile manufacture of liquids, injectables and aerosol dosage forms, product and process development, and process validation. Previously, Mr. Katzer was Vice President of Manufacturing at Medimmune Vaccines, Inc. where he was responsible for the overall leadership of worldwide vaccine manufacturing operations, including bulk virus manufacturing, formulation, filling, packaging and distribution. While at Medimmune, Mr. Katzer was instrumental in the organizational and technical transition from contract manufacturing to company managed operations. Prior to that, Mr. Katzer was Vice President of Pharmaceutical Operations at US Bioscience, where he managed regulatory cGMP inspections of European and United States operating facilities. Earlier in his career, Mr. Katzer held senior operating positions at Rhone Poulenc Rorer Pharmaceuticals. Mr. Katzer received his B.S. degree from the University of Wisconsin. | 